mRNA |
lenalidomide |
FIMM |
pan-cancer |
AAC |
-0.36 |
0.04 |
mRNA |
lapatinib |
gCSI |
pan-cancer |
AAC |
0.11 |
0.04 |
mRNA |
ABT-737 |
CTRPv2 |
pan-cancer |
AAC |
-0.073 |
0.04 |
mRNA |
BRD-K66532283 |
CTRPv2 |
pan-cancer |
AAC |
-0.068 |
0.04 |
mRNA |
Vandetanib |
CCLE |
pan-cancer |
AAC |
0.096 |
0.04 |
mRNA |
Lisitinib |
GDSC1000 |
pan-cancer |
AAC |
0.068 |
0.04 |
mRNA |
PD-0325901 |
gCSI |
pan-cancer |
AAC |
0.1 |
0.04 |
mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.067 |
0.05 |
mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.07 |
0.05 |
mRNA |
PHA-665752 |
CCLE |
pan-cancer |
AAC |
0.094 |
0.05 |